BELLUS Health Alpha and Beta Analysis
BLUDelisted Stock | USD 14.74 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BELLUS Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in BELLUS Health over a specified time horizon. Remember, high BELLUS Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BELLUS Health's market risk premium analysis include:
Beta 2.86 | Alpha 1.38 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BELLUS |
BELLUS Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BELLUS Health market risk premium is the additional return an investor will receive from holding BELLUS Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BELLUS Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BELLUS Health's performance over market.α | 1.38 | β | 2.86 |
BELLUS Health Fundamentals Vs Peers
Comparing BELLUS Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BELLUS Health's direct or indirect competition across all of the common fundamentals between BELLUS Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as BELLUS Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BELLUS Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing BELLUS Health by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare BELLUS Health to competition |
Fundamentals | BELLUS Health | Peer Average |
Return On Equity | -0.27 | -0.31 |
Return On Asset | -0.17 | -0.14 |
Current Valuation | 1.56 B | 16.62 B |
Shares Outstanding | 126.81 M | 571.82 M |
Shares Owned By Insiders | 10.26 % | 10.09 % |
Shares Owned By Institutions | 90.41 % | 39.21 % |
Number Of Shares Shorted | 6.65 M | 4.71 M |
BELLUS Health Opportunities
BELLUS Health Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
Timeline |
1 | Super Mario Bros. Movie Now Available on DVD, Blu-ray, HD SteelbookGet Your Hands on a Copy Now | 04/05/2023 |
2 | BELLUS Health Hits New 52-Week High at 7.28 | 04/17/2023 |
3 | Slide in commodity prices pushes TSX futures lower | 04/19/2023 |
4 | BRODSKY SMITH SHAREHOLDER UPDATE Notifying Investors of the Following Investigations Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences... | 04/25/2023 |
5 | BELLUS Health GH Research Financial Survey | 04/28/2023 |
6 | BELLUS Health Brief Comes After Co Announced agreement to be Acquired by GSK for US14.75 per share of common stock in cash - Marketscreener.com | 05/12/2023 |
7 | Market Highlights AI frenzy loses shine as FANG drops 3pc Coinbase says its business as usual | 06/07/2023 |
8 | Moore Capital Management LP Decreases Stock Holdings in BELLUS Health Inc. | 06/13/2023 |
9 | GSK Reaches Settlement In U.S. Zantac Litigation - Marketscreener.com | 06/22/2023 |
10 | Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health - Yahoo Finance | 06/28/2023 |
About BELLUS Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BELLUS or other delisted stocks. Alpha measures the amount that position in BELLUS Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
BELLUS Health Upcoming Company Events
As portrayed in its financial statements, the presentation of BELLUS Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BELLUS Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of BELLUS Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of BELLUS Health. Please utilize our Beneish M Score to check the likelihood of BELLUS Health's management manipulating its earnings.
9th of August 2023 Upcoming Quarterly Report | View | |
13th of November 2023 Next Financial Report | View | |
30th of June 2023 Next Fiscal Quarter End | View | |
19th of March 2024 Next Fiscal Year End | View | |
31st of March 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Build Portfolio with BELLUS Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in BELLUS Stock
If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |